Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

MITRA

Mithra Pharmaceuticals (MITRA)

Mithra Pharmaceuticals SA

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:EU:MITRA

1 2 3 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
03/05/2024	17h30	GlobeNewswire Inc.	Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process	EU:MITRA	Mithra Pharmaceuticals SA
29/04/2024	07h00	GlobeNewswire Inc.	Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023	EU:MITRA	Mithra Pharmaceuticals SA
22/04/2024	07h00	GlobeNewswire Inc.	Mithra secures court protection measures to advance monetization process	EU:MITRA	Mithra Pharmaceuticals SA
08/03/2024	07h00	GlobeNewswire Inc.	Mithra reports full year 2023 financial results	EU:MITRA	Mithra Pharmaceuticals SA
05/03/2024	07h01	GlobeNewswire Inc.	Mithra announces changes to its executive management	EU:MITRA	Mithra Pharmaceuticals SA
05/03/2024	07h00	GlobeNewswire Inc.	Mithra initiates monetization process, receives bridge loan from existing lenders	EU:MITRA	Mithra Pharmaceuticals SA
29/02/2024	11h42	GlobeNewswire Inc.	DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase	EU:MITRA	Mithra Pharmaceuticals SA
15/02/2024	18h23	GlobeNewswire Inc.	Mithra sells shares in Mayne Pharma	EU:MITRA	Mithra Pharmaceuticals SA
06/02/2024	07h00	GlobeNewswire Inc.	Mithra updates on cash position	EU:MITRA	Mithra Pharmaceuticals SA
06/02/2024	07h00	GlobeNewswire Inc.	Mithra updates on cash position	EU:MITRA	Mithra Pharmaceuticals SA
21/12/2023	17h45	GlobeNewswire Inc.	Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel	EU:MITRA	Mithra Pharmaceuticals SA
21/12/2023	17h45	GlobeNewswire Inc.	Mithra and Rafa Laboratories sign binding Head of Terms to commercialize DONESTA® in Israel	EU:MITRA	Mithra Pharmaceuticals SA
20/12/2023	17h45	GlobeNewswire Inc.	Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients	EU:MITRA	Mithra Pharmaceuticals SA
20/12/2023	17h45	GlobeNewswire Inc.	Mithra Completes Pediatric Study of ESTELLE® in Adolescent Patients	EU:MITRA	Mithra Pharmaceuticals SA
18/12/2023	07h00	GlobeNewswire Inc.	Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial	EU:MITRA	Mithra Pharmaceuticals SA
18/12/2023	07h00	GlobeNewswire Inc.	Mithra Receives Positive DSMB Opinion on DONESTA® European Phase 3 Trial	EU:MITRA	Mithra Pharmaceuticals SA
04/12/2023	07h00	GlobeNewswire Inc.	Mithra and Gedeon Richter sign binding Head of Terms to commercialize ESTELLE® and DONESTA® in China	EU:MITRA	Mithra Pharmaceuticals SA
30/11/2023	07h00	GlobeNewswire Inc.	Mithra receives guidance from the FDA for the DONESTA® NDA marketing authorization filing in the United States	EU:MITRA	Mithra Pharmaceuticals SA
28/11/2023	17h45	GlobeNewswire Inc.	Mithra to hold five presentations on key role of estrogens in women’s health, including Estetrol (E4), at the ESG Congress in Amsterdam	EU:MITRA	Mithra Pharmaceuticals SA
07/11/2023	07h00	GlobeNewswire Inc.	Mithra’s NEXTSTELLIS® granted additional patent in the United States	EU:MITRA	Mithra Pharmaceuticals SA
07/11/2023	07h00	GlobeNewswire Inc.	Mithra’s NEXTSTELLIS® granted additional patent in the United States	EU:MITRA	Mithra Pharmaceuticals SA
06/11/2023	18h52	GlobeNewswire Inc.	Mithra releases invitation to its extraordinary securities holders’ meeting	EU:MITRA	Mithra Pharmaceuticals SA
26/10/2023	07h00	GlobeNewswire Inc.	Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada	EU:MITRA	Mithra Pharmaceuticals SA
23/10/2023	07h00	GlobeNewswire Inc.	Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement	EU:MITRA	Mithra Pharmaceuticals SA
23/10/2023	07h00	GlobeNewswire Inc.	Mithra to receive EUR 2.5 million milestone payment from Fuji Pharma under ESTELLE® licensing agreement	EU:MITRA	Mithra Pharmaceuticals SA
17/10/2023	07h00	GlobeNewswire Inc.	Mithra’s Board of Directors to propose the removal of its request for change of the remuneration policy at the Special General Meeting	EU:MITRA	Mithra Pharmaceuticals SA
11/10/2023	07h15	GlobeNewswire Inc.	Shareholder Letter	EU:MITRA	Mithra Pharmaceuticals SA
11/10/2023	07h00	GlobeNewswire Inc.	Mithra announces update to the agenda of its upcoming special general shareholders’ meeting	EU:MITRA	Mithra Pharmaceuticals SA
10/10/2023	18h00	GlobeNewswire Inc.	Mithra to Hold Presentations on Key Role of Estrogens in Women’s Health, Including Estetrol (E4), at FIGO World Congress	EU:MITRA	Mithra Pharmaceuticals SA
05/10/2023	07h00	GlobeNewswire Inc.	Mithra Provides an Update in the Context of Recent Market Developments	EU:MITRA	Mithra Pharmaceuticals SA

Showing the most relevant articles for your search:EU:MITRA

1 2 3 Next >>

BNP Paribas (QX)

Deutsche Lufthansa

Euro vs Sterling

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen